Pfizer (PFE) Income towards Parent Company (2009 - 2026)
Pfizer (PFE) posted Income towards Parent Company of -$248 million for Q2 2026, compared with $2.91 billion a year earlier.
Powered by 
Analysis
Pfizer (PFE) Income towards Parent Company (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 28, 2026, Income towards Parent Company at Pfizer was $4.33 billion, down 59.7% year-over-year; for FY2025, it came in at $7.77 billion, down 3.2% from FY2024.
- Annual Income towards Parent Company shows a five-year compound annual growth rate of -3.2% (FY2020 to FY2025).
- In prior years, Pfizer's Income towards Parent Company was $8.03 billion in FY2024 (+279.0%), $2.12 billion in FY2023 (-93.2%), $31.37 billion in FY2022 (+42.7%) and $21.98 billion in FY2021 (+140.0%).
- Quarterly Income towards Parent Company has run from a low of -$3.37 billion in Q4 2023 to a high of $9.91 billion in Q2 2022 over five years.
- The strongest year-over-year quarter for Income towards Parent Company in the past five years was Q3 2021, with growth of 454.5%; the weakest was Q2 2024, with a decline of 98.2%.
- According to Business Quant data, Income towards Parent Company for the three prior quarters was $2.69 billion (Q1 2026), -$1.65 billion (Q4 2025) and $3.54 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -248.00 Mn |
| Mar 29, 2026 | 2.69 Bn |
| Dec 31, 2025 | -1.65 Bn |
| Sep 28, 2025 | 3.54 Bn |
| Jun 29, 2025 | 2.91 Bn |
| Mar 30, 2025 | 2.97 Bn |
| Dec 31, 2024 | 410.00 Mn |
| Sep 29, 2024 | 4.47 Bn |
| Jun 30, 2024 | 41.00 Mn |
| Mar 31, 2024 | 3.12 Bn |
| Dec 31, 2023 | -3.37 Bn |
| Oct 1, 2023 | -2.38 Bn |
| Jul 2, 2023 | 2.33 Bn |
| Apr 2, 2023 | 5.54 Bn |
| Dec 31, 2022 | 4.99 Bn |
| Oct 2, 2022 | 8.61 Bn |
| Jul 3, 2022 | 9.91 Bn |
| Apr 3, 2022 | 7.86 Bn |
| Dec 31, 2021 | 3.39 Bn |
| Oct 3, 2021 | 8.15 Bn |
API Access
Pfizer Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();